ICON Plc (ICLR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
November 2018
61
About the Report
About the Report
Summary
ICON plc (ICON) is a contract research organization (CRO) that provides outsourced development services to the biotechnology, pharmaceutical and medical device industries worldwide. It provides a range of specialized services that span the entire lifecycle of product development. The company's service portfolio includes adaptive trials, biosimilars, clinical research services, commercialization and outcomes, consulting, functional services provision, medical imaging, laboratory services, resourcing solutions and strategic support and tactical solutions for traditional, in vitro diagnostic, and software devices. The company offers research services in areas such as cancer, genomics, central nervous system, cardiovascular, endocrine and metabolic disorders, gastrointestinal, medical device, nonalcoholic steatohepatitis (NASH), ophthalmology, rare and orphan diseases, transplant and immunology, vaccines, women's health therapeutics and other therapeutic areas. ICON is headquartered in Dublin, Ireland.
ICON Plc (ICLR)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
ICON Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
ICON Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
ICON Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
ICON Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
ICON Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
ICON Plc, Medical Devices Deals, 2012 to YTD 2018 10
ICON Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
ICON Plc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Icon Completes Acquisition Of Clinical Trial Services Business From Cross Country Healthcare For Up To USD 56 Million 12
Venture Financing 13
Aptiv Solutions Raises USD 5.7 Million In Venture Financing 13
Merger 14
Inclinix Merges With PMG Research 14
Licensing Agreements 15
Aptiv Solutions Enters Into Licensing Agreement With Tessella For FACTS, Adaptive Trial Design Software 15
Debt Offering 16
ICON Raises USD350 Million in Private Placement of 3.64% Notes Due 2020 16
Acquisition 17
ICON Acquires Mapi 17
Icon Acquires Clinical Research Management 18
Icon Acquires PMG Research from Frontier Capital 19
ICON Acquires MediMedia Pharma Solutions for USD120 Million 20
Icon Completes Acquisition Of Aptiv Solutions For USD 143.5 Million 21
Icon Completes Acquisition Of BeijingWits Medical Consulting, Contract Research Organization 23
ICON Plc-Key Competitors 24
ICON Plc-Key Employees 25
ICON Plc-Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 29
Strategy And Business Planning 29
Mar 29, 2018: ICON Helps Establish New Industry Standards Group to Improve Clinical Trial Collaboration and Execution 29
Mar 14, 2018: ICON opens a new office in Boston 30
Financial Announcements 31
Oct 24, 2018: ICON Reports Third Quarter 2018 Results 31
Oct 24, 2018: ICON reports third quarter 2018 results 33
Jul 25, 2018: ICON Reports Second Quarter 2018 Results 35
May 02, 2018: ICON Reports First Quarter 2018 Results 37
Feb 15, 2018: ICON Reports Fourth Quarter and Full Year 2017 Results 38
Jan 09, 2018: ICON Issues Financial Guidance for Full Year 2018 40
Oct 26, 2017: ICON Reports Third Quarter 2017 Results 41
Jul 27, 2017: ICON Reports Second Quarter 2017 Results 42
Apr 27, 2017: ICON Reports First Quarter 2017 Results 43
Feb 16, 2017: ICON Reports Fourth Quarter and Full Year 2016 Results 44
Jan 09, 2017: ICON Issues Financial Guidance for Full Year 2017 45
Corporate Communications 46
Jul 27, 2018: ICON Confirms Retirement of Co-Founder Dr. Ronan Lambe 46
Jan 09, 2018: ICON Appoints Dr. James Cummings as President of ClinicalRM 47
Nov 17, 2017: ICON Announces Appointment of Ms. Joan Garahy to Board of Directors 48
Oct 04, 2017: ICON Announces Appointment of Mr. Eugene McCague to Board of Directors 49
Government and Public Interest 50
Mar 27, 2018: Leading CROs Form New Industry Standards Group to Improve Collaboration with Sponsors 50
Product News 52
Nov 21, 2017: ICON Launches FIRECREST Pre-Screen to Improve the Speed and Accuracy of Identifying Eligible Patients for Screening 52
Nov 07, 2017: ICON contributes to major European research study that aims to improve treatment for traumatic brain injury 53
Feb 20, 2017: ICON Selected by the FDA to Validate Patient-Reported Outcome Endpoints for Antibacterial Drug Trials 54
Other Significant Developments 55
Oct 01, 2018: ICON announces release of ADDPLAN Neo 55
Jun 22, 2018: ICON and DIA driving Insights to Action with DIA Live 2018 56
Apr 03, 2018: ICON announces launch of Government and Public Health Solutions to support global public health 57
Nov 21, 2017: FIRECREST Pre-Screen improves sponsor visibility of patient access 58
Nov 06, 2017: ICON Reveals Voice-Assistant Applications for Clinical Trials at ISPOR Annual European Congress 59
Oct 27, 2017: ICON and ICHOM unveil the world's first global patient outcomes benchmarking platform 60
Appendix 61
Methodology 61
About GlobalData 61
Contact Us 61
Disclaimer 61
List of Figure
List of Figures
ICON Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ICON Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ICON Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ICON Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ICON Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
ICON Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
ICON Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
ICON Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
ICON Plc, Medical Devices Deals, 2012 to YTD 2018 10
List of Table
List of Tables
ICON Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
ICON Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
ICON Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
ICON Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
ICON Plc, Deals By Therapy Area, 2012 to YTD 2018 9
ICON Plc, Medical Devices Deals, 2012 to YTD 2018 10
ICON Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Icon Completes Acquisition Of Clinical Trial Services Business From Cross Country Healthcare For Up To USD 56 Million 12
Aptiv Solutions Raises USD 5.7 Million In Venture Financing 13
Inclinix Merges With PMG Research 14
Aptiv Solutions Enters Into Licensing Agreement With Tessella For FACTS, Adaptive Trial Design Software 15
ICON Raises USD350 Million in Private Placement of 3.64% Notes Due 2020 16
ICON Acquires Mapi 17
Icon Acquires Clinical Research Management 18
Icon Acquires PMG Research from Frontier Capital 19
ICON Acquires MediMedia Pharma Solutions for USD120 Million 20
Icon Completes Acquisition Of Aptiv Solutions For USD 143.5 Million 21
Icon Completes Acquisition Of BeijingWits Medical Consulting, Contract Research Organization 23
ICON Plc, Key Competitors 24
ICON Plc, Key Employees 25
ICON Plc, Subsidiaries 26
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.